✦ LIBER ✦

Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancer

✍ Scribed by D.W. van Toorn; J.W.R Nortier; M. Rubach; C.A.M. de Swart; J.C. Huldij; H. van Tinteren; J.B. Vermorken; J.B. Vermorken

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5164 POSTER Phase II Study of Neoadjuvan

✍ Ikeda, T.; Kamo, N.; Shiga, C.; Sasajima, Y.; Imamura, T. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

2095 POSTER A randomized, open-label CEC

✍ S. Kahan; S. Spanik; M. Wagnerova; T. Skacel; B. Planko; E. Fitzthum; E. Lindner 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Randomized phase II trial of gemcitabine

✍ Cathy CROMBIE; W Ivon BURNS; Christos KARAPETIS; Ray M LOWENTHAL; Fred KIRSTEN; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

781 A randomized phase II trial of gemci

✍ J. Iglesias; C. Crombie; W.I. Burns; C. Karapetis; R.M. Lowenthal; F. Kirsten; J 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Paclitaxel administration on days 1 and

✍ M. Donadio; E. Manzin; A. Berruti; A. Bottini; G. Gorzegno; S. Danese; E. DeFabi 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 92 KB

PP-7-1 phase II study of liarozole in ad

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 150 KB